Top News

SteadyMed Therapeutics Finds $3M In Working Capital

San Ramon-based SteadyMed Therapeutics, a developer of biopharmaceuticals to treat Pulmonary Arterial Hypertension (PAH), has raised $3M in a term loan from Square 1 Bank. Square 1 Bank said the loan will go towards working capital, to help the firm continue development of its technology. Terms of the loan were not announced by Square 1.


 

Marketplace


blog comments powered by Disqus
 

Latest Headlines

Browse Issues